Literature DB >> 30602443

Levels of Mycoplasma genitalium Antimicrobial Resistance Differ by Both Region and Gender in the State of Queensland, Australia: Implications for Treatment Guidelines.

E L Sweeney1, E Trembizki2, C Bletchly3, C S Bradshaw4, A Menon5, F Francis6, J Langton-Lockton7, G R Nimmo3, D M Whiley2,3.   

Abstract

Mycoplasma genitalium is frequently associated with urogenital and rectal infections, with the number of cases of macrolide-resistant and quinolone-resistant M. genitalium infection continuing to increase. In this study, we examined the levels of resistance to these two common antibiotic treatments in geographically distinct locations in Queensland, Australia. Samples were screened for macrolide resistance-associated mutations using a commercially available kit (ResistancePlus MG; SpeeDx), and quinolone resistance-associated mutations were identified by PCR and DNA sequencing. Comparisons between antibiotic resistance mutations and location/gender were performed. The levels of M. genitalium macrolide resistance were high across both locations (62%). Quinolone resistance mutations were found in ∼10% of all samples, with a number of samples harboring mutations conferring resistance to both macrolides and quinolones. Quinolone resistance was higher in southeast Queensland than in north Queensland, and this was consistent in both males and females (P = 0.007). The M. genitalium isolates in rectal swab samples from males harbored high levels of macrolide (75.9%) and quinolone (19%) resistance, with 15.5% harboring resistance to both classes of antibiotics. Overall, the lowest observed level of resistance was to quinolones in females from north Queensland (1.6%). These data highlight the high levels of antibiotic resistance in M. genitalium isolates within Queensland and the challenges faced by sexually transmitted infection clinicians in managing these infections. The data do, however, show that the levels of antibiotic resistance may differ between populations within the same state, which has implications for clinical management and treatment guidelines. These findings also support the need for ongoing antibiotic resistance surveillance and tailored treatment.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Australia; Mycoplasma genitaliumzzm321990; Queensland; antimicrobial resistance; azithromycin; macrolide; moxifloxacin; quinolone; sexually transmitted infection

Mesh:

Substances:

Year:  2019        PMID: 30602443      PMCID: PMC6425175          DOI: 10.1128/JCM.01555-18

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  32 in total

1.  Mycoplasma genitalium infection and persistence in a cohort of female sex workers in Nairobi, Kenya.

Authors:  Craig R Cohen; Marcianna Nosek; Amalia Meier; Sabina G Astete; Stefanie Iverson-Cabral; Nelly R Mugo; Patricia A Totten
Journal:  Sex Transm Dis       Date:  2007-05       Impact factor: 2.830

2.  Comparison of full gyrA, gyrB, parC and parE gene sequences between all Ureaplasma parvum and Ureaplasma urealyticum serovars to separate true fluoroquinolone antibiotic resistance mutations from non-resistance polymorphism.

Authors:  Michael L Beeton; Victoria J Chalker; Sailesh Kotecha; O Brad Spiller
Journal:  J Antimicrob Chemother       Date:  2009-06-30       Impact factor: 5.790

3.  Mycoplasma genitalium Macrolide and Fluoroquinolone Resistance: Prevalence and Risk Factors Among a 2013-2014 Cohort of Patients in Barcelona, Spain.

Authors:  María-Jesús Barberá; Miguel Fernández-Huerta; Jørgen-Skov Jensen; Estrella Caballero; Antonia Andreu
Journal:  Sex Transm Dis       Date:  2017-08       Impact factor: 2.830

4.  High Macrolide Resistance in Mycoplasma genitalium Strains Causing Infection in Auckland, New Zealand.

Authors:  Indira Basu; Sally A Roberts; James E Bower; Gillian Henderson; Murray Reid
Journal:  J Clin Microbiol       Date:  2017-05-03       Impact factor: 5.948

Review 5.  Mycoplasma genitalium: from Chrysalis to multicolored butterfly.

Authors:  David Taylor-Robinson; Jørgen Skov Jensen
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

6.  Azithromycin 1.5g Over 5 Days Compared to 1g Single Dose in Urethral Mycoplasma genitalium: Impact on Treatment Outcome and Resistance.

Authors:  Tim R H Read; Christopher K Fairley; Sepehr N Tabrizi; Melanie Bissessor; Lenka Vodstrcil; Eric P F Chow; Mieken Grant; Jennifer Danielewski; Suzanne M Garland; Jane S Hocking; Marcus Y Chen; Catriona S Bradshaw
Journal:  Clin Infect Dis       Date:  2016-10-24       Impact factor: 9.079

7.  Emergence of clinical strains of Mycoplasma genitalium harbouring alterations in ParC associated with fluoroquinolone resistance.

Authors:  Yasushi Shimada; Takashi Deguchi; Keita Nakane; Takako Masue; Mitsuru Yasuda; Shigeaki Yokoi; Shin-ichi Ito; Masahiro Nakano; Shin Ito; Hiroaki Ishiko
Journal:  Int J Antimicrob Agents       Date:  2010-06-30       Impact factor: 5.283

8.  A newly discovered mycoplasma in the human urogenital tract.

Authors:  J G Tully; D Taylor-Robinson; R M Cole; D L Rose
Journal:  Lancet       Date:  1981-06-13       Impact factor: 79.321

9.  Mutations in ParC and GyrA of moxifloxacin-resistant and susceptible Mycoplasma genitalium strains.

Authors:  Ryoichi Hamasuna; Phuong Thi Le; Satoshi Kutsuna; Keiichi Furubayashi; Masahiro Matsumoto; Norio Ohmagari; Naohiro Fujimoto; Tetsuro Matsumoto; Jorgen Skov Jensen
Journal:  PLoS One       Date:  2018-06-08       Impact factor: 3.240

10.  Mycoplasma genitalium in the Far North Queensland backpacker population: An observational study of prevalence and azithromycin resistance.

Authors:  Thomas Trevis; Marianne Gossé; Nicola Santarossa; Sepehr Tabrizi; Darren Russell; William John McBride
Journal:  PLoS One       Date:  2018-08-28       Impact factor: 3.240

View more
  10 in total

1.  Evaluation of the SpeeDx MG parC (Beta) PCR Assay for Rapid Detection of Mycoplasma genitalium Quinolone Resistance-Associated Mutations.

Authors:  Emma L Sweeney; Kym Lowry; Samantha Ebeyan; Marie Lundgren; David M Whiley
Journal:  J Clin Microbiol       Date:  2020-09-22       Impact factor: 5.948

2.  Genotyping of Mycoplasma genitalium Suggests De Novo Acquisition of Antimicrobial Resistance in Queensland, Australia.

Authors:  Emma L Sweeney; Jacob Tickner; Cheryl Bletchly; Graeme R Nimmo; David M Whiley
Journal:  J Clin Microbiol       Date:  2020-08-24       Impact factor: 5.948

3.  Evaluation of the ResistancePlus MG FleXible Cartridge for Near-Point-of-Care Testing of Mycoplasma genitalium and Associated Macrolide Resistance Mutations.

Authors:  E L Sweeney; L P Mhango; S Ebeyan; L Y Tan; C Bletchly; G R Nimmo; D M Whiley
Journal:  J Clin Microbiol       Date:  2020-02-24       Impact factor: 5.948

Review 4.  Mycoplasma genitalium: A new superbug.

Authors:  J Stephen Raj; Jyoti Rawre; Neha Dhawan; Neena Khanna; Benu Dhawan
Journal:  Indian J Sex Transm Dis AIDS       Date:  2022-06-07

5.  Novel probe-based melting curve assays for the characterization of fluoroquinolone resistance in Mycoplasma genitalium.

Authors:  Jacob A Tickner; Catriona S Bradshaw; Gerald L Murray; David M Whiley; Emma L Sweeney
Journal:  J Antimicrob Chemother       Date:  2022-05-29       Impact factor: 5.758

6.  Molecular Typing of Mycoplasma genitalium-Positive Specimens Discriminates between Persistent and Recurrent Infections in Cases of Treatment Failure and Supports Contact Tracing.

Authors:  Luis Piñeiro; Pedro Idigoras; Gustavo Cilla
Journal:  Microorganisms       Date:  2019-11-23

7.  Macrolide and fluoroquinolone associated mutations in Mycoplasma genitalium in a retrospective study of male and female patients seeking care at a STI Clinic in Guangzhou, China, 2016-2018.

Authors:  Wujian Ke; Dongling Li; Lai Sze Tso; Ran Wei; Yinyuan Lan; Zhengyu Chen; Xiaohui Zhang; Liuyuan Wang; Chunmei Liang; Yuying Liao; Huiru Chen; Yahui Liu; Heping Zheng; Ligang Yang
Journal:  BMC Infect Dis       Date:  2020-12-11       Impact factor: 3.090

8.  Exploring the implications for coincidental treatment of Mycoplasma genitalium infection in Neisseria gonorrhoeae-positive patients.

Authors:  Lebogang P Mhango; Ella Trembizki; Caroline Thng; David M Whiley; Emma L Sweeney
Journal:  JAC Antimicrob Resist       Date:  2021-03-16

9.  Outbreak of multi-drug-resistant (MDR) Shigella flexneri in northern Australia due to an endemic regional clone acquiring an IncFII plasmid.

Authors:  Christine J D Guglielmino; Asha Kakkanat; Brian M Forde; Sally Rubenach; Lea Merone; Russell Stafford; Rikki M A Graham; Scott A Beatson; Amy V Jennison
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-09-04       Impact factor: 3.267

10.  Modelling the multiple anatomical site transmission of Mycoplasma genitalium among men who have sex with men in Australia.

Authors:  Xianglong Xu; Catriona S Bradshaw; Eric P F Chow; Jason J Ong; Jane S Hocking; Christopher K Fairley; Lei Zhang
Journal:  Sci Rep       Date:  2021-05-27       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.